Tgf-beta3-induced palatal fusion is mediated by Alk-5/Smad pathway (Q28239297)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14729481%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

title

Tgf-beta3-induced palatal fusion is mediated by Alk-5/Smad pathway (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14729481%20AND%20SRC:MED&resulttype=core&format=json

Transforming growth factor beta-3

17 November 2019

main subject

1 reference

Activin A receptor, type 1

GOA release 2020-03-11

1 reference

Transforming growth factor, beta receptor I

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

author

Vesa Kaartinen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14729481%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Marek Dudas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14729481%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

author name string

Andre Nagy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14729481%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Nicholas J Laping

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14729481%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Aristidis Moustakas

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14729481%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

language of work or name

English

0 references

publication date

1 February 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14729481%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

published in

Developmental Biology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14729481%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

volume

266

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14729481%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14729481%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

page(s)

96-108

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14729481%20AND%20SRC:MED&resulttype=core&format=json

Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration.

17 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

TGF-beta3-induced palatogenesis requires matrix metalloproteinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

Identification of novel inhibitors of the transforming growth factor beta1 (TGF-beta1) type 1 receptor (ALK5).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

Programmed cell death is required for palate shelf fusion and is regulated by retinoic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

TGF-beta3-dependent SMAD2 phosphorylation and inhibition of MEE proliferation during palatal fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

Specificity and mechanism of action of some commonly used protein kinase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

A kinase subdomain of transforming growth factor-beta (TGF-beta) type I receptor determines the TGF-beta intracellular signaling specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

Postgastrulation Smad2-deficient embryos show defects in embryo turning and anterior morphogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

Elucidation of Smad requirement in transforming growth factor-beta type I receptor-induced responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

PI-3 kinase activity is required for epithelial-mesenchymal transformation during palate fusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

Nuclear factor YY1 inhibits transforming growth factor beta- and bone morphogenetic protein-induced cell differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

Activin receptor-like kinase 2 can mediate atrioventricular cushion transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

Association of MSX1 and TGFB3 with nonsyndromic clefting in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

TGF-beta signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

How cells read TGF-beta signals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

Multiple roles for activin-like kinase-2 signaling during mouse embryogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

Sensitive nonradioactive detection of mRNA in tissue sections: novel application of the whole-mount in situ hybridization protocol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

From mono- to oligo-Smads: the heart of the matter in TGF-beta signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

Smad2 role in mesoderm formation, left-right patterning and craniofacial development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

Specificity, diversity, and regulation in TGF-beta superfamily signaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

Transforming growth factor-beta 3 is required for secondary palate fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

Smad3 allostery links TGF-beta receptor kinase activation to transcriptional control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

The orphan receptor ALK7 and the Activin receptor ALK4 mediate signaling by Nodal proteins during vertebrate development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

Smad-dependent GADD45beta expression mediates delayed activation of p38 MAP kinase by TGF-beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

Smad2 signaling in extraembryonic tissues determines anterior-posterior polarity of the early mouse embryo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

Failure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor smad2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

Inhibition of transforming growth factor-beta signaling by low molecular weight compounds interfering with ATP- or substrate-binding sites of the TGF beta type I receptor kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007

Smad3 mutant mice develop metastatic colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2003.10.007